Healthcare provider profile · identity verified

Andrew T Kwan, MD

Family Practice · TOPEKA, KS · NPI 1497288146

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	340	93
Levothyroxine Sodium	Levothyroxine Sodium	255	57
Amlodipine Besylate	Amlodipine Besylate	213	61
Gabapentin	Gabapentin	206	47
Pantoprazole Sodium	Pantoprazole Sodium	196	51
Trazodone Hcl	Trazodone Hcl	182	39
Escitalopram Oxalate	Escitalopram Oxalate	180	45
Tamsulosin Hcl	Tamsulosin Hcl	172	52
Albuterol Sulfate Hfa	Albuterol Sulfate	161	44
Oxycodone Hcl	Oxycodone Hcl	147	27
Lisinopril	Lisinopril	134	35
Losartan Potassium	Losartan Potassium	131	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	130	29
Metformin Hcl	Metformin Hcl	125	32
Donepezil Hcl	Donepezil Hcl	120	24
Omeprazole	Omeprazole	120	34
Aripiprazole	Aripiprazole	118	20
Potassium Chloride	Potassium Chloride	116	27
Ozempic	Semaglutide	112	23
Mounjaro	Tirzepatide	108	24
Metoprolol Succinate	Metoprolol Succinate	94	30
Tizanidine Hcl	Tizanidine Hcl	92	24
Hydrochlorothiazide	Hydrochlorothiazide	90	22
Memantine Hcl	Memantine Hcl	90	18
Furosemide	Furosemide	88	26
Jardiance	Empagliflozin	84	18
Simvastatin	Simvastatin	83	18
Meloxicam	Meloxicam	78	33
Duloxetine Hcl	Duloxetine Hcl	77	22
Rosuvastatin Calcium	Rosuvastatin Calcium	77	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	76	17
Pregabalin	Pregabalin	75	18
Allopurinol	Allopurinol	74	16
Carvedilol	Carvedilol	74	21
Alendronate Sodium	Alendronate Sodium	73	27
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	70	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	70	17
Prednisone	Prednisone	69	54
Montelukast Sodium	Montelukast Sodium	67	19
Buspirone Hcl	Buspirone Hcl	64	14
Tramadol Hcl	Tramadol Hcl	64	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	25
Fluticasone Propionate	Fluticasone Propionate	58	23
Hydroxyzine Hcl	Hydroxyzine Hcl	58	13
Eliquis	Apixaban	56	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	55	suppressed
Topiramate	Topiramate	55	11
Famotidine	Famotidine	50	14
Zolpidem Tartrate	Zolpidem Tartrate	50	12
Azithromycin	Azithromycin	49	30
Quetiapine Fumarate	Quetiapine Fumarate	46	suppressed
Atenolol	Atenolol	45	suppressed
Hydralazine Hcl	Hydralazine Hcl	44	suppressed
Lorazepam	Lorazepam	44	13
Diclofenac Sodium	Diclofenac Sodium	43	15
Ondansetron Odt	Ondansetron	43	17
Atomoxetine Hcl	Atomoxetine Hcl	42	suppressed
Solifenacin Succinate	Solifenacin Succinate	42	suppressed
Clonazepam	Clonazepam	41	suppressed
Glimepiride	Glimepiride	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Metformin Hcl Er	Metformin Hcl	38	suppressed
Bupropion Xl	Bupropion Hcl	37	11
Mirtazapine	Mirtazapine	37	suppressed
Sertraline Hcl	Sertraline Hcl	37	suppressed
Varenicline Tartrate	Varenicline Tartrate	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Alprazolam	Alprazolam	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Cephalexin	Cephalexin	34	23
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Terbinafine Hcl	Terbinafine Hcl	33	20
Levetiracetam	Levetiracetam	32	suppressed
Finasteride	Finasteride	29	suppressed
Ketoconazole	Ketoconazole	29	15
Modafinil	Modafinil	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Nystatin	Nystatin	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Clobetasol Propionate	Clobetasol Propionate	24	13
Farxiga	Dapagliflozin Propanediol	24	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Primidone	Primidone	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Dutasteride	Dutasteride	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Benztropine Mesylate	Benztropine Mesylate	18	suppressed
Ciclopirox	Ciclopirox	18	suppressed
Mupirocin	Mupirocin	18	suppressed
Ranolazine Er	Ranolazine	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	14
Diazepam	Diazepam	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Torsemide	Torsemide	17	suppressed
Breyna	Budesonide/Formoterol Fumarate	16	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Erythromycin	Erythromycin Base	16	suppressed
Linzess	Linaclotide	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Baclofen	Baclofen	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Irbesartan	Irbesartan	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Wegovy	Semaglutide	13	suppressed
Xifaxan	Rifaximin	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Naproxen	Naproxen	12	suppressed
Risperidone	Risperidone	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	11
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Glipizide	Glipizide	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error